Stoke Therapeutics, Inc. SEC filings STOK
Stoke Therapeutics, Inc. has 632 filings in SEC EDGAR's recent list, going back to Nov 24, 2014. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 11, 2025 | — |
| CORRESP | Letter to the SEC | Jul 9, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2025 | — |
| DRSLTR | Filing | Jun 26, 2025 | — |
| DRS | Filing | Jun 26, 2025 | — |
| EFFECT | Filing | Jun 20, 2024 | — |
| CORRESP | Letter to the SEC | Jun 17, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2024 | — |
| SC TO-I/A | Filing | Dec 5, 2023 | — |
| SC TO-I/A | Filing | Nov 17, 2023 | — |
| CORRESP | Letter to the SEC | Nov 17, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| SC TO-I/A | Filing | Nov 9, 2023 | — |
| SC TO-I | Filing | Nov 2, 2023 | — |
| EFFECT | Filing | May 31, 2022 | — |
| CORRESP | Letter to the SEC | May 26, 2022 | — |
| UPLOAD | Letter from the SEC | May 25, 2022 | — |
| EFFECT | Filing | Jul 20, 2020 | — |
| CORRESP | Letter to the SEC | Jul 16, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2020 | — |
| EFFECT | Filing | Jun 18, 2019 | — |
| CORRESP | Letter to the SEC | Jun 14, 2019 | — |
| CORRESP | Letter to the SEC | Jun 14, 2019 | — |
| CERT | 8-a cert | Jun 13, 2019 | — |
| SEC STAFF LETTER | Filing | Jun 13, 2019 | — |
| CORRESP | Letter to the SEC | Jun 12, 2019 | — |
| 8-A12B | Filing | Jun 11, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2019 | — |
| CORRESP | Letter to the SEC | Jun 7, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2019 | — |
| SEC STAFF LETTER | Filing | Jun 3, 2019 | — |
| CORRESP | Letter to the SEC | Jun 3, 2019 | — |
| CORRESP | Letter to the SEC | May 23, 2019 | — |
| UPLOAD | Letter from the SEC | May 14, 2019 | — |
| DRSLTR | Filing | Apr 30, 2019 | — |
| DRS/A | Filing | Apr 30, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2019 | — |
| DRS | Filing | Mar 26, 2019 | — |
| D | Filing | Nov 2, 2018 | — |
| D | Filing | Nov 24, 2014 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- STOK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedford, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1623526
- Former names
- ASOthera Pharmaceuticals, Inc. (until Nov 24, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.